Company · CIK 0001720893 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
BioXcel Therapeutics, Inc. · BTAI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 MForm 4 → | Jun 17, 8:01 pm EDT | Javier RodriguezSee Remarks | 35 | — | — | 26,838 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:00 pm EDT | Richard I SteinhartChief Financial Officer | 35 | — | — | 26,335 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:00 pm EDT | Frank YoccaChief Scientific Officer | 35 | — | — | 26,210 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:00 pm EDT | Vimal MehtaCEO and President, Director | 219 | — | — | 69,817 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 AForm 4 → | Aug 14, 7:00 pm EDT | Susan E. AtkinsDirector | 17,000 | — | — | 17,000 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:01 pm EDT | Javier RodriguezSee Remarks | 35 | — | — | 212 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:00 pm EDT | Richard I SteinhartChief Financial Officer | 35 | — | — | 212 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:00 pm EDT | Frank YoccaChief Scientific Officer | 35 | — | — | 212 | — | |
| Jun 15, 2026 MForm 4 → | Jun 17, 8:00 pm EDT | Vimal MehtaCEO and President, Director | 219 | — | — | 1,313 | — |